Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-07-01
1999-08-17
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514259, 544279, 544293, A01N 4354, C07D47100, C07D23972
Patent
active
059394218
ABSTRACT:
Compounds having utility as anti-inflammatory agents in general and, more specifically, for the prevention and/or treatment of immunoinflammatory and autoimmune diseases are disclosed. The compounds are quinazoline-containing compounds. Methods are also disclosed for preventing and/or treating inflammatory conditions by administering to an animal in need thereof an effective amount of a compound of this invention, preferably in the form of a pharmaceutical composition.
REFERENCES:
patent: 4322420 (1982-03-01), Kobayashi et al.
El-Sherief et al., "Quinazoline Derivatives from 2-Phenyl-4-quinazolinylhydrazine," Bull. Chem. Soc. Jpn. 57(4): 1138-1142, 1984.
El-Bahaie et. al., "Reactions with 4-Carboxymethylthio . . . ", Chem. Abs., vol. 116, ABS #151703W, p. 874, 1992.
Palanki Moorthy S. S.
Suto Mark J.
Shah Mukund J.
Signal Pharmaceuticals Inc.
Truong Tamthom N.
LandOfFree
Quinazoline analogs and related compounds and methods for treati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazoline analogs and related compounds and methods for treati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline analogs and related compounds and methods for treati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-314994